Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
38.6M
-
Shares change
-
+1.37M
-
Total reported value, excl. options
-
$71.7M
-
Value change
-
+$2.58M
-
Number of buys
-
18
-
Number of sells
-
-26
-
Price
-
$1.86
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2022
64 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.6M shares
of 72.1M outstanding shares and own 53.51% of the company stock.
Largest 10 shareholders include BVF INC/IL (6.85M shares), Rubric Capital Management LP (6.83M shares), EcoR1 Capital, LLC (6.12M shares), Madison Avenue Partners, LP (2.72M shares), VANGUARD GROUP INC (2.58M shares), Artal Group S.A. (2.5M shares), ACADIAN ASSET MANAGEMENT LLC (1.81M shares), TLS Advisors LLC (1.49M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.43M shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (911K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.